Carboplatin is a derivative of cisplatin; it has a similar mechanism of action, but differs in terms of structure and toxicity. It was approved by the FDA in the 1980s and since then it has been widel
# Synthetic KYC/AML Compliance Test Data — Preview **5 preview records** from Sovereign Forger's Born-Synthetic KYC/AML dataset. The full sample (100 records) is available for free at [sovereignforge
Oncogenic addiction to FLT3 kinase signaling is a hallmark of FLT3-ITD+ acute myeloid leukemia (AML). While FLT3 inhibitors like sorafenib show initial therapeutic efficacy, resistance rapidly develop